#nanobody — Public Fediverse posts

How Nanobody Technology Can Redefine Respiratory Care

Asthma, COPD, and CRSwNP are complex, heterogeneous conditions, often driven by multiple overlapping inflammatory pathways rather than a single one. When one pathway…
#France #FR #Europe #EU #Sanofi #asthma #COPD #CRSwNP #Nanobody #respiratorydiseases
https://www.europesays.com/france/77455/

A neutralizing #nanobody targeting a conserved lateral patch on HA1 confers #protection against multiple #H7 avian #influenza viruses, https://etidiohnew.blogspot.com/2026/06/a-neutralizing-nanobody-targeting.html

A neutralizing #nanobody targeting a conserved lateral patch on HA1 confers #protection against multiple #H7 avian #influenza viruses, https://etidiohnew.blogspot.com/2026/06/a-neutralizing-nanobody-targeting.html

A neutralizing #nanobody targeting a conserved lateral patch on HA1 confers #protection against multiple #H7 avian #influenza viruses, https://etidiohnew.blogspot.com/2026/06/a-neutralizing-nanobody-targeting.html

A neutralizing #nanobody targeting a conserved lateral patch on HA1 confers #protection against multiple #H7 avian #influenza viruses, https://etidiohnew.blogspot.com/2026/06/a-neutralizing-nanobody-targeting.html

#Biofilm matrices containing filamentous phages help #Pseudomonas aeruginosa tolerate antibiotics. @tbharat_lab &co show that #nanobody disruption of #phage Pf4 #LiquidCrystalline droplets restores #antibiotic susceptibility @PLOSBiology https://plos.io/4xkd6Mw

#Biofilm matrices containing filamentous phages help #Pseudomonas aeruginosa tolerate antibiotics. @tbharat_lab &co show that #nanobody disruption of #phage Pf4 #LiquidCrystalline droplets restores #antibiotic susceptibility @PLOSBiology https://plos.io/4xkd6Mw

#Biofilm matrices containing filamentous phages help #Pseudomonas aeruginosa tolerate antibiotics. @tbharat_lab &co show that #nanobody disruption of #phage Pf4 #LiquidCrystalline droplets restores #antibiotic susceptibility @PLOSBiology https://plos.io/4xkd6Mw

#Biofilm matrices containing filamentous phages help #Pseudomonas aeruginosa tolerate antibiotics. @tbharat_lab &co show that #nanobody disruption of #phage Pf4 #LiquidCrystalline droplets restores #antibiotic susceptibility @PLOSBiology https://plos.io/4xkd6Mw

Press Release: Sanofi’s lunsekimig met primary and key

Sanofi’s lunsekimig met primary and key secondary endpoints in phase 2 respiratory studies in asthma and CRSwNP  The AIRCULES phase…
#France #FR #Europe #EU #Sanofi #asthma #asthme #clinicalresearch #Cytokines #essaiscliniques #health #inflammation #maladiesrespiratoires #Nanobody #ParisStockExchange:SAN #Pharmaceuticals #respiratorydisease #SanofiWinthropIndustrie #Santé
https://www.europesays.com/france/30955/

Nanobody Tech: Multi-Targeting for Complex Disease Therapies

In late 19th century Germany, the rise of diphtheria and tetanus had researchers racing to find treatments. In…
#France #FR #Europe #EU #Sanofi #antibody #drugdiscovery #innovation #Nanobody
https://www.europesays.com/france/21812/

https://www.europesays.com/at/111413/ Forscher finden neuen Therapieansatz bei seltener Krankheit #100137924 #100601380 #Antikörperbaustein #AT #Austria #Berlin #Charite #Gesundheit #Health #Mukoviszidose #Nanobody #Österreich #therapieansatz #Zellgängige

♨️ Hot off the press: Researchers at #CharitéBerlin & FMP have developed a fundamentally new therapeutic approach to the hereditary disease #CysticFibrosis! They succeeded in repairing the causal cell defect with a #nanobody – a tiny antibody fragment – in the lab.

👉 https://www.charite.de/en/service/press_reports/artikel/detail/a_fundamentally_new_therapeutic_approach_to_cystic_fibrosis_nanobody_repairs_cellular_defect

#CharitéPaper #CharitéPediatrics #CF #CysticFibrosis #medicine #research #science #chemistry #MedMastodon #ScienceMastodon #pharmacology

♨️ Hot off the press: Researchers at #CharitéBerlin & FMP have developed a fundamentally new therapeutic approach to the hereditary disease #CysticFibrosis! They succeeded in repairing the causal cell defect with a #nanobody – a tiny antibody fragment – in the lab.

👉 https://www.charite.de/en/service/press_reports/artikel/detail/a_fundamentally_new_therapeutic_approach_to_cystic_fibrosis_nanobody_repairs_cellular_defect

#CharitéPaper #CharitéPediatrics #CF #CysticFibrosis #medicine #research #science #chemistry #MedMastodon #ScienceMastodon #pharmacology

♨️ Hot off the press: Researchers at #CharitéBerlin & FMP have developed a fundamentally new therapeutic approach to the hereditary disease #CysticFibrosis! They succeeded in repairing the causal cell defect with a #nanobody – a tiny antibody fragment – in the lab.

👉 https://www.charite.de/en/service/press_reports/artikel/detail/a_fundamentally_new_therapeutic_approach_to_cystic_fibrosis_nanobody_repairs_cellular_defect

#CharitéPaper #CharitéPediatrics #CF #CysticFibrosis #medicine #research #science #chemistry #MedMastodon #ScienceMastodon #pharmacology

♨️ Hot off the press: Researchers at #CharitéBerlin & FMP have developed a fundamentally new therapeutic approach to the hereditary disease #CysticFibrosis! They succeeded in repairing the causal cell defect with a #nanobody – a tiny antibody fragment – in the lab.

👉 https://www.charite.de/en/service/press_reports/artikel/detail/a_fundamentally_new_therapeutic_approach_to_cystic_fibrosis_nanobody_repairs_cellular_defect

#CharitéPaper #CharitéPediatrics #CF #CysticFibrosis #medicine #research #science #chemistry #MedMastodon #ScienceMastodon #pharmacology

♨️ Hot off the press: Forschende von #CharitéBerlin & FMP haben einen grundlegend neuen Therapieansatz gegen die Erbkrankheit #Mukoviszidose entwickelt! Es ist ihnen gelungen, den ursächlichen Zelldefekt mit einem #Nanobody – einem winzigen Antikörperbaustein – im Labor zu reparieren.

👉 https://www.charite.de/service/pressemitteilung/artikel/detail/grundlegend_neuer_therapieansatz_gegen_mukoviszidose_nanobody_repariert_zelldefekt

#CharitéPaper #CharitéPädiatrie
#CF #CystischeFibrose #Medizin #Forschung #Wissenschaft #Chemie #MedMastodon #ScienceMastodon #Pharmakologie

♨️ Hot off the press: Forschende von #CharitéBerlin & FMP haben einen grundlegend neuen Therapieansatz gegen die Erbkrankheit #Mukoviszidose entwickelt! Es ist ihnen gelungen, den ursächlichen Zelldefekt mit einem #Nanobody – einem winzigen Antikörperbaustein – im Labor zu reparieren.

👉 https://www.charite.de/service/pressemitteilung/artikel/detail/grundlegend_neuer_therapieansatz_gegen_mukoviszidose_nanobody_repariert_zelldefekt

#CharitéPaper #CharitéPädiatrie
#CF #CystischeFibrose #Medizin #Forschung #Wissenschaft #Chemie #MedMastodon #ScienceMastodon #Pharmakologie

♨️ Hot off the press: Forschende von #CharitéBerlin & FMP haben einen grundlegend neuen Therapieansatz gegen die Erbkrankheit #Mukoviszidose entwickelt! Es ist ihnen gelungen, den ursächlichen Zelldefekt mit einem #Nanobody – einem winzigen Antikörperbaustein – im Labor zu reparieren.

👉 https://www.charite.de/service/pressemitteilung/artikel/detail/grundlegend_neuer_therapieansatz_gegen_mukoviszidose_nanobody_repariert_zelldefekt

#CharitéPaper #CharitéPädiatrie
#CF #CystischeFibrose #Medizin #Forschung #Wissenschaft #Chemie #MedMastodon #ScienceMastodon #Pharmakologie

♨️ Hot off the press: Forschende von #CharitéBerlin & FMP haben einen grundlegend neuen Therapieansatz gegen die Erbkrankheit #Mukoviszidose entwickelt! Es ist ihnen gelungen, den ursächlichen Zelldefekt mit einem #Nanobody – einem winzigen Antikörperbaustein – im Labor zu reparieren.

👉 https://www.charite.de/service/pressemitteilung/artikel/detail/grundlegend_neuer_therapieansatz_gegen_mukoviszidose_nanobody_repariert_zelldefekt

#CharitéPaper #CharitéPädiatrie
#CF #CystischeFibrose #Medizin #Forschung #Wissenschaft #Chemie #MedMastodon #ScienceMastodon #Pharmakologie

🧪 August’s most-read Biochemistry paper presents an alternative platform for #nanobody discovery using phage-displayed synthetic libraries: https://elifesciences.org/articles/105887?utm_source=mastodon&utm_medium=social&utm_campaign=submissions_organic&utm_content=top_paper

Have a paper people should see? See what our Editors look for: https://elifesciences.org/about/aims-scope?utm_source=mastodon&utm_medium=social&utm_campaign=submissions_organic&utm_content=top_paper#biochemistry-and-chemical-biology

🧪 August’s most-read Biochemistry paper presents an alternative platform for #nanobody discovery using phage-displayed synthetic libraries: https://elifesciences.org/articles/105887?utm_source=mastodon&utm_medium=social&utm_campaign=submissions_organic&utm_content=top_paper

Have a paper people should see? See what our Editors look for: https://elifesciences.org/about/aims-scope?utm_source=mastodon&utm_medium=social&utm_campaign=submissions_organic&utm_content=top_paper#biochemistry-and-chemical-biology

🧪 August’s most-read Biochemistry paper presents an alternative platform for #nanobody discovery using phage-displayed synthetic libraries: https://elifesciences.org/articles/105887?utm_source=mastodon&utm_medium=social&utm_campaign=submissions_organic&utm_content=top_paper

Have a paper people should see? See what our Editors look for: https://elifesciences.org/about/aims-scope?utm_source=mastodon&utm_medium=social&utm_campaign=submissions_organic&utm_content=top_paper#biochemistry-and-chemical-biology

🧪 August’s most-read Biochemistry paper presents an alternative platform for #nanobody discovery using phage-displayed synthetic libraries: https://elifesciences.org/articles/105887?utm_source=mastodon&utm_medium=social&utm_campaign=submissions_organic&utm_content=top_paper

Have a paper people should see? See what our Editors look for: https://elifesciences.org/about/aims-scope?utm_source=mastodon&utm_medium=social&utm_campaign=submissions_organic&utm_content=top_paper#biochemistry-and-chemical-biology

Eine gute Nachricht.

https://idw-online.de/de/news857576

#medizin #herpes #nanobody #uh

🤖 Can algorithms outsmart evolution to create therapies humans never imagined?

🔗 Computational nanobody design through deep generative modeling and epitope landscape profiling. Computational and Structural Biotechnology Journal, DOI: https://doi.org/10.1016/j.csbj.2025.07.052

📚 CSBJ: https://www.csbj.org/

#Nanobody #AI #DeepLearning #ProteinDesign #DrugDiscovery #ComputationalBiology #GenerativeAI #Immunotherapy #COVID19 #SARSCoV2 #Omicron #AntibodyEngineering #SyntheticBiology #TranslationalResearch

🦙 Nanobody neutralizes deadly Nipah and Hendra viruses in lab tests

https://phys.org/news/2025-07-nanobody-neutralizes-deadly-nipah-hendra.html

#medicine #healthcare #nanobody #drugs #pharmacology #disease #virus

🦙 Nanobody neutralizes deadly Nipah and Hendra viruses in lab tests

https://phys.org/news/2025-07-nanobody-neutralizes-deadly-nipah-hendra.html

#medicine #healthcare #nanobody #drugs #pharmacology #disease #virus

🦙 Nanobody neutralizes deadly Nipah and Hendra viruses in lab tests

https://phys.org/news/2025-07-nanobody-neutralizes-deadly-nipah-hendra.html

#medicine #healthcare #nanobody #drugs #pharmacology #disease #virus

🦙 Nanobody neutralizes deadly Nipah and Hendra viruses in lab tests

https://phys.org/news/2025-07-nanobody-neutralizes-deadly-nipah-hendra.html

#medicine #healthcare #nanobody #drugs #pharmacology #disease #virus

A #nanobody-based #therapeutic targeting #Nipah virus limits viral escape, https://etidiohnew.blogspot.com/2025/07/a-nanobody-based-therapeutic-targeting.html

A #nanobody-based #therapeutic targeting #Nipah virus limits viral escape, https://etidiohnew.blogspot.com/2025/07/a-nanobody-based-therapeutic-targeting.html

A #nanobody-based #therapeutic targeting #Nipah virus limits viral escape, https://etidiohnew.blogspot.com/2025/07/a-nanobody-based-therapeutic-targeting.html

A #nanobody-based #therapeutic targeting #Nipah virus limits viral escape, https://etidiohnew.blogspot.com/2025/07/a-nanobody-based-therapeutic-targeting.html

#Nanobody neutralizes deadly #Nipah and #Hendra #viruses in lab tests

https://phys.org/news/2025-07-nanobody-neutralizes-deadly-nipah-hendra.html

#Nanobody neutralizes deadly #Nipah and #Hendra #viruses in lab tests

https://phys.org/news/2025-07-nanobody-neutralizes-deadly-nipah-hendra.html

#Nanobody neutralizes deadly #Nipah and #Hendra #viruses in lab tests

https://phys.org/news/2025-07-nanobody-neutralizes-deadly-nipah-hendra.html

#Nanobody neutralizes deadly #Nipah and #Hendra #viruses in lab tests

https://phys.org/news/2025-07-nanobody-neutralizes-deadly-nipah-hendra.html

Identification and characterization of a broadly neutralizing and protective #nanobody against the #HA1 domain of #H5 avian #influenza virus #hemagglutinin, https://etidiohnew.blogspot.com/2025/04/identification-and-characterization-of.html

Identification and characterization of a broadly neutralizing and protective #nanobody against the #HA1 domain of #H5 avian #influenza virus #hemagglutinin, https://etidiohnew.blogspot.com/2025/04/identification-and-characterization-of.html

Identification and characterization of a broadly neutralizing and protective #nanobody against the #HA1 domain of #H5 avian #influenza virus #hemagglutinin, https://etidiohnew.blogspot.com/2025/04/identification-and-characterization-of.html

Identification and characterization of a broadly neutralizing and protective #nanobody against the #HA1 domain of #H5 avian #influenza virus #hemagglutinin, https://etidiohnew.blogspot.com/2025/04/identification-and-characterization-of.html

#Influenza A Virus #H7 #nanobody recognizes a conserved immunodominant epitope on #hemagglutinin head and confers heterosubtypic #protection

Source: BioRxIV, AbstractInfluenza remains a persistent global health challenge, largely due to the virus continuous antigenic drift and shift, which impede the development of a universal vaccine. To address this, the identification of broadly neutralizing antibodies and their epitopes is crucial. Nanobodies, with their unique…

https://etidioh.wordpress.com/2024/11/01/influenza-a-virus-h7-nanobody-recognizes-a-conserved-immunodominant-epitope-on-hemagglutinin-head-and-confers-heterosubtypic-protection/

#Influenza A Virus #H7 #nanobody recognizes a conserved immunodominant epitope on #hemagglutinin head and confers heterosubtypic #protection

Source: BioRxIV, AbstractInfluenza remains a persistent global health challenge, largely due to the virus continuous antigenic drift and shift, which impede the development of a universal vaccine. To address this, the identification of broadly neutralizing antibodies and their epitopes is crucial. Nanobodies, with their unique…

https://etidioh.wordpress.com/2024/11/01/influenza-a-virus-h7-nanobody-recognizes-a-conserved-immunodominant-epitope-on-hemagglutinin-head-and-confers-heterosubtypic-protection/

#Influenza A Virus #H7 #nanobody recognizes a conserved immunodominant epitope on #hemagglutinin head and confers heterosubtypic #protection

Source: BioRxIV, AbstractInfluenza remains a persistent global health challenge, largely due to the virus continuous antigenic drift and shift, which impede the development of a universal vaccine. To address this, the identification of broadly neutralizing antibodies and their epitopes is crucial. Nanobodies, with their unique…

https://etidioh.wordpress.com/2024/11/01/influenza-a-virus-h7-nanobody-recognizes-a-conserved-immunodominant-epitope-on-hemagglutinin-head-and-confers-heterosubtypic-protection/

#Influenza A Virus #H7 #nanobody recognizes a conserved immunodominant epitope on #hemagglutinin head and confers heterosubtypic #protection

Source: BioRxIV, AbstractInfluenza remains a persistent global health challenge, largely due to the virus continuous antigenic drift and shift, which impede the development of a universal vaccine. To address this, the identification of broadly neutralizing antibodies and their epitopes is crucial. Nanobodies, with their unique…

https://etidioh.wordpress.com/2024/11/01/influenza-a-virus-h7-nanobody-recognizes-a-conserved-immunodominant-epitope-on-hemagglutinin-head-and-confers-heterosubtypic-protection/

2018 erhielt mit Caplacizumab der erste therapeutische #Nanobody die Zulassung. Trotz einiger zwischenzeitlicher Pleiten könnten bald weitere folgen … Kathleen Gransalke fasst den Stand der Dinge zusammen: https://www.laborjournal.de/editorials/3014.php

2018 erhielt mit Caplacizumab der erste therapeutische #Nanobody die Zulassung. Trotz einiger zwischenzeitlicher Pleiten könnten bald weitere folgen … Kathleen Gransalke fasst den Stand der Dinge zusammen: https://www.laborjournal.de/editorials/3014.php

2018 erhielt mit Caplacizumab der erste therapeutische #Nanobody die Zulassung. Trotz einiger zwischenzeitlicher Pleiten könnten bald weitere folgen … Kathleen Gransalke fasst den Stand der Dinge zusammen: https://www.laborjournal.de/editorials/3014.php

2018 erhielt mit Caplacizumab der erste therapeutische #Nanobody die Zulassung. Trotz einiger zwischenzeitlicher Pleiten könnten bald weitere folgen … Kathleen Gransalke fasst den Stand der Dinge zusammen: https://www.laborjournal.de/editorials/3014.php

Die Münchner von Plectonic Biotech wollen #Krebszellen mit #DNAOrigami an den Kragen. Zuerst mussten die „tollkühnen Physiker“ aber lernen, mit #Zellen zu arbeiten. Wie das lief und was dabei herauskam, erzählt Tobias Ludwig: 👉 https://www.laborjournal.de/editorials/2665.php

#biotech #startup #nanobody

Die Münchner von Plectonic Biotech wollen #Krebszellen mit #DNAOrigami an den Kragen. Zuerst mussten die „tollkühnen Physiker“ aber lernen, mit #Zellen zu arbeiten. Wie das lief und was dabei herauskam, erzählt Tobias Ludwig: 👉 https://www.laborjournal.de/editorials/2665.php

#biotech #startup #nanobody

Die Münchner von Plectonic Biotech wollen #Krebszellen mit #DNAOrigami an den Kragen. Zuerst mussten die „tollkühnen Physiker“ aber lernen, mit #Zellen zu arbeiten. Wie das lief und was dabei herauskam, erzählt Tobias Ludwig: 👉 https://www.laborjournal.de/editorials/2665.php

#biotech #startup #nanobody

Nice and concise #review about the different #methods to increase effective molecular weight of #proteins <100 ​kDa through target protein binding or target protein fusion (#nanobody and symmetric #scaffolds) enabling structure determination with #cryoEM @strucbio

https://www.sciencedirect.com/science/article/pii/S2665928X22000290

Nice and concise #review about the different #methods to increase effective molecular weight of #proteins <100 ​kDa through target protein binding or target protein fusion (#nanobody and symmetric #scaffolds) enabling structure determination with #cryoEM @strucbio

https://www.sciencedirect.com/science/article/pii/S2665928X22000290

Nice and concise #review about the different #methods to increase effective molecular weight of #proteins <100 ​kDa through target protein binding or target protein fusion (#nanobody and symmetric #scaffolds) enabling structure determination with #cryoEM @strucbio

https://www.sciencedirect.com/science/article/pii/S2665928X22000290